The European cosmetics market is entering a strict new phase of compliance. Following the notification of draft Commission Regulation G/TBT/N/EU/1219 to the World Trade Organization (WTO) in July 2026, the European Commission is advancing a sweeping set of updates to the Annexes of Regulation (EC) No 1223/2009. Combining recent Scientific Committee on Consumer Safety (SCCS) opinions with the latest round of CMR-related prohibitions (Omnibus CMR IX), these updates introduce severe restrictions and outright bans on several widely used ingredients.
For cosmetics manufacturers, formulators, and regulatory affairs officers, label updates will not suffice. Proving compliance with the new thresholds requires quantitative analytical data and comprehensive laboratory testing. With a strict transition period on the horizon, brands must act immediately to keep noncompliant products away from market and prepare for the forced withdrawal of existing stock.
Need to verify your formula meets the new EU 1223/2009 Annex restrictions?
Submit a request to find an accredited analytical testing lab.
The Major Ingredient Casualties
The incoming updates strictly target ingredients flagged for endocrine disruption, toxicity, or trace impurities. Here is what is changing for formulations currently on the market:
- The CBD Crackdown: Cannabidiol (CBD) is facing strict limitations under Annex III. It is capped at a maximum concentration of 0.19% in cosmetic products. Crucially, the permitted trace level for tetrahydrocannabinol (THC) impurities is set at a microscopic 0.00025% (2.5 ppm).
- The Benzophenone Ban: Common UV light stabilizers, including certain benzophenones, will be strictly prohibited per recent SCCS opinions and CMR classifications. Formulators relying on these compounds to protect products from UV degradation or to stabilize color must find immediate alternatives.
- BHA Limitations: The antioxidant butylated hydroxyanisole (BHA) is now restricted to a maximum of 0.07% in leave-on and rinse-off products, and is strictly prohibited in oral care and products that may expose the end user’s lungs upon inhalation.
- Preservative Overhauls: The draft removes the remaining legacy exemptions for mercury-containing preservatives, rendering them fully banned.
Formulating Your Fix: The Required Laboratory Testing
When an ingredient is banned or restricted, brands are forced into a costly cycle of reformulation. You cannot simply swap an ingredient or lower a concentration without re-evaluating the entire formula’s integrity. To legally maintain market access in the EU, brands must secure updated testing data across several categories.
1. Analytical Testing (HPLC/GC-MS)
If your brand retains CBD in a formulation, you must legally prove to your EU Responsible Person that THC impurities fall below the 2.5-ppm limit. This requires HPLC or GC-MS to detect trace cannabinoids with absolute precision. Similarly, analytical testing is necessary to verify that raw materials and supplier blends are free from newly banned contaminants.
2. Preservative Efficacy Testing (PET) / Challenge Testing
Removing legacy preservatives—or altering the chemical environment by reducing antioxidants like BHA—can compromise a product’s ability to resist microbial growth. Any reformulated water-based cosmetic must undergo a 28-day microbial challenge test (PET) against standard pathogens, such as S. aureus and P. aeruginosa, to ensure consumer safety.
3. Accelerated Stability Testing
Swapping out UV stabilizers alters a product’s chemical and physical stability. When removing benzophenones, the replacement formula must undergo accelerated thermal and UV stability testing to confirm it will not separate, degrade, or shift in color over its intended shelf life. Accelerated stability protocols typically require 12 weeks of elevated temperature exposure to project a standard two-year shelf life.
Reformulating due to the Annex II and III updates?
Submit a single request to receive quotes from multiple cosmetics stability and challenge testing laboratories.
Updating Your Product Information File (PIF) and CPSR
The European Union requires every cosmetic product to maintain an up-to-date PIF, which houses the cosmetic product safety report (CPSR).
A certified toxicologist must sign off on the CPSR before a product can be sold. Crucially, a toxicologist will not approve a newly reformulated product without fresh laboratory data. The analytical, stability, and microbiological test reports detailed above must be appended directly to the PIF. If your PIF lacks current testing data reflecting the new Annex II and III restrictions, the product is illegal to sell within the EU.
Beat the Transition Period
Regulatory transition periods move fast. For the non-CMR ingredient changes, the proposed transition offers 12 months after entry into force to halt placing noncompliant formulations on the Union market, and 24 months before existing noncompliant inventory must be pulled from European shelves. CMR-related measures often enforce even tighter timelines.
Because stability testing alone takes a minimum of three months—and lab capacity tightens as deadlines approach—delaying your reformulation strategy is a massive commercial risk. Find the right Lab to fit your needs by submitting a request with Contract Laboratory today to connect with our network of accredited cosmetics testing facilities.
Are you an analytical or microbiological laboratory equipped to perform HPLC, GC-MS, or PET challenge testing?
Join the Contract Laboratory network to receive incoming test requests and partner with beauty brands urgently navigating these new EU compliance standards.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.